CN113480512B - 一种1-(7-溴苯并并[d][1,3]二氧杂环戊烯-4-基)乙-1-酮的制备方法 - Google Patents
一种1-(7-溴苯并并[d][1,3]二氧杂环戊烯-4-基)乙-1-酮的制备方法 Download PDFInfo
- Publication number
- CN113480512B CN113480512B CN202110839803.6A CN202110839803A CN113480512B CN 113480512 B CN113480512 B CN 113480512B CN 202110839803 A CN202110839803 A CN 202110839803A CN 113480512 B CN113480512 B CN 113480512B
- Authority
- CN
- China
- Prior art keywords
- formula
- reaction
- compound
- preparation
- compound shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 47
- -1 [1,3] dioxol-4-yl Chemical group 0.000 title claims abstract description 17
- 238000006243 chemical reaction Methods 0.000 claims abstract description 31
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims abstract description 10
- 238000005917 acylation reaction Methods 0.000 claims abstract description 6
- 238000005893 bromination reaction Methods 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 6
- 238000010511 deprotection reaction Methods 0.000 claims abstract description 4
- 150000001875 compounds Chemical class 0.000 claims description 95
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 24
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 22
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 claims description 19
- JOXIMZWYDAKGHI-UHFFFAOYSA-N p-toluenesulfonic acid Substances CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 10
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 claims description 9
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 claims description 8
- 239000012346 acetyl chloride Substances 0.000 claims description 8
- 238000006138 lithiation reaction Methods 0.000 claims description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052794 bromium Inorganic materials 0.000 claims description 7
- 239000003054 catalyst Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 2
- 125000005489 p-toluenesulfonic acid group Chemical group 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 4
- 239000003999 initiator Substances 0.000 abstract description 2
- 235000002566 Capsicum Nutrition 0.000 abstract 1
- 239000006002 Pepper Substances 0.000 abstract 1
- 235000016761 Piper aduncum Nutrition 0.000 abstract 1
- 235000017804 Piper guineense Nutrition 0.000 abstract 1
- 244000203593 Piper nigrum Species 0.000 abstract 1
- 235000008184 Piper nigrum Nutrition 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 238000001816 cooling Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000004321 preservation Methods 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 229960005235 piperonyl butoxide Drugs 0.000 description 5
- 238000010791 quenching Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000012065 filter cake Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 125000001979 organolithium group Chemical group 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 3
- 235000019345 sodium thiosulphate Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 125000004591 piperonyl group Chemical group C(C1=CC=2OCOC2C=C1)* 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 208000006154 Chronic hepatitis C Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000010710 hepatitis C virus infection Diseases 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
Abstract
Description
式(II)所示化合物的制备 | 制备例1 | 制备例2 | 制备例3 | 制备对比例1 |
有机锂 | 正丁基锂 | 正丁基锂 | 正丁基锂 | 二异丙基氨基锂 |
胡椒环、有机锂和乙酰氯的摩尔比 | 1:1.89:1.10 | 1:1.89:1.20 | 1:1.89:1.10 | 1:1.89:1.10 |
收率 | 93.97% | 92.40% | 89.50% | 68.68% |
式(III)所示化合物的制备 | 制备例1 | 制备例2 | 制备例3 |
式(II)所示化合物、乙二醇和对甲苯磺酸的摩尔比 | 1:1.20:0.103 | 1:1.20:0.104 | 1:1.20:0.096 |
收率 | 93.32% | 93.86% | 95.82% |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110839803.6A CN113480512B (zh) | 2021-07-23 | 2021-07-23 | 一种1-(7-溴苯并并[d][1,3]二氧杂环戊烯-4-基)乙-1-酮的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110839803.6A CN113480512B (zh) | 2021-07-23 | 2021-07-23 | 一种1-(7-溴苯并并[d][1,3]二氧杂环戊烯-4-基)乙-1-酮的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113480512A CN113480512A (zh) | 2021-10-08 |
CN113480512B true CN113480512B (zh) | 2022-07-29 |
Family
ID=77942380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110839803.6A Active CN113480512B (zh) | 2021-07-23 | 2021-07-23 | 一种1-(7-溴苯并并[d][1,3]二氧杂环戊烯-4-基)乙-1-酮的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113480512B (zh) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1659144A (zh) * | 2002-04-02 | 2005-08-24 | 舍林股份公司 | 喹啉和异喹啉衍生物、其制备方法以及作为炎症抑制剂的应用 |
CN101157679A (zh) * | 2007-11-15 | 2008-04-09 | 上海化学试剂研究所 | N-乙基-3,4-(亚甲二氧基)苯胺的制备方法 |
WO2009064251A1 (en) * | 2007-11-15 | 2009-05-22 | Astrazeneca Ab | Bis-(sulfonylamino) derivatives in therapy 066 |
CN108675998A (zh) * | 2018-06-28 | 2018-10-19 | 北京凯因科技股份有限公司 | 一种结晶性氨基甲酸甲酯类化合物 |
CN108904496A (zh) * | 2018-06-28 | 2018-11-30 | 北京凯因科技股份有限公司 | 用于治疗丙型肝炎感染的药物组合物 |
CN109419806A (zh) * | 2017-08-23 | 2019-03-05 | 南京圣和药业股份有限公司 | 抗病毒组合物及其应用 |
WO2019200005A1 (en) * | 2018-04-10 | 2019-10-17 | Atea Pharmaceuticals, Inc. | Treatment of hcv infected patients with cirrhosis |
CN111072625A (zh) * | 2019-12-06 | 2020-04-28 | 浙江理工大学 | 一种3,4-亚甲二氧苯乙酮的制备方法 |
WO2020117966A1 (en) * | 2018-12-05 | 2020-06-11 | Atea Pharmaceuticals, Inc. | Highly active drug combination for treatment of hepatitis c virus |
CN112358462A (zh) * | 2020-11-10 | 2021-02-12 | 成都伊诺达博医药科技有限公司 | 一种胡椒环衍生物的合成方法 |
CN113603670A (zh) * | 2021-07-23 | 2021-11-05 | 阜阳欣奕华制药科技有限公司 | 一种制备1-(7-溴苯并并[d][1,3]二氧杂环戊烯-4-基)乙-1-酮的方法 |
-
2021
- 2021-07-23 CN CN202110839803.6A patent/CN113480512B/zh active Active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1659144A (zh) * | 2002-04-02 | 2005-08-24 | 舍林股份公司 | 喹啉和异喹啉衍生物、其制备方法以及作为炎症抑制剂的应用 |
CN101157679A (zh) * | 2007-11-15 | 2008-04-09 | 上海化学试剂研究所 | N-乙基-3,4-(亚甲二氧基)苯胺的制备方法 |
WO2009064251A1 (en) * | 2007-11-15 | 2009-05-22 | Astrazeneca Ab | Bis-(sulfonylamino) derivatives in therapy 066 |
CN109419806A (zh) * | 2017-08-23 | 2019-03-05 | 南京圣和药业股份有限公司 | 抗病毒组合物及其应用 |
WO2019200005A1 (en) * | 2018-04-10 | 2019-10-17 | Atea Pharmaceuticals, Inc. | Treatment of hcv infected patients with cirrhosis |
CN108675998A (zh) * | 2018-06-28 | 2018-10-19 | 北京凯因科技股份有限公司 | 一种结晶性氨基甲酸甲酯类化合物 |
CN108904496A (zh) * | 2018-06-28 | 2018-11-30 | 北京凯因科技股份有限公司 | 用于治疗丙型肝炎感染的药物组合物 |
WO2020001089A1 (zh) * | 2018-06-28 | 2020-01-02 | 北京凯因格领生物技术有限公司 | 一种结晶性氨基甲酸甲酯类化合物 |
WO2020117966A1 (en) * | 2018-12-05 | 2020-06-11 | Atea Pharmaceuticals, Inc. | Highly active drug combination for treatment of hepatitis c virus |
CN111072625A (zh) * | 2019-12-06 | 2020-04-28 | 浙江理工大学 | 一种3,4-亚甲二氧苯乙酮的制备方法 |
CN112358462A (zh) * | 2020-11-10 | 2021-02-12 | 成都伊诺达博医药科技有限公司 | 一种胡椒环衍生物的合成方法 |
CN113603670A (zh) * | 2021-07-23 | 2021-11-05 | 阜阳欣奕华制药科技有限公司 | 一种制备1-(7-溴苯并并[d][1,3]二氧杂环戊烯-4-基)乙-1-酮的方法 |
Non-Patent Citations (1)
Title |
---|
盐酸可洛派韦在HCV感染者中的耐受性和药代动力学;娄金凤等;《临床肝胆病杂志》;20210630;第37卷(第6期);第1304-1308页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113480512A (zh) | 2021-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002224131A1 (en) | Process for producing 5-(3-cyanophenyl)-3-formylbenzoic acid compound | |
US20100249439A1 (en) | Process for controlled crystal size in 1,2-substituted 3,4-dioxo-1-cyclobutene compounds | |
CN112062712A (zh) | 一种2-(5-溴-3-甲基吡啶-2-基)乙酸盐酸盐的制备方法 | |
US20050192351A1 (en) | Process for the preparation of 13-cis-retinoic acid | |
CN113480512B (zh) | 一种1-(7-溴苯并并[d][1,3]二氧杂环戊烯-4-基)乙-1-酮的制备方法 | |
CN106928149B (zh) | 一种奥拉帕尼的制备方法 | |
CN113603670B (zh) | 一种制备1-(7-溴苯并并[d][1,3]二氧杂环戊烯-4-基)乙-1-酮的方法 | |
CN116606236A (zh) | 一种6-苄氧基色氨酸的合成方法 | |
CN114014864B (zh) | 一种曲拉西利化合物的制备工艺 | |
CN108586529A (zh) | 一种含有联苯骨架的手性化合物及其制备方法与应用 | |
CN110590601B (zh) | 一种丙二腈的合成方法 | |
CN113277984A (zh) | 一种制备3,6-二氯哒嗪-4-醇的方法 | |
CN113024375A (zh) | 一种反,反-4-烷基-4′-戊基-3(e)烯-双环己烷类液晶单体的制备方法 | |
CN112341313A (zh) | 3,5-二氯苯甲醇及羧胺***中间体的制备方法 | |
CN112028874A (zh) | 艾立替尼的合成方法 | |
WO2016115962A1 (zh) | 一种奈必洛尔中间体的制备方法及奈必洛尔的制备方法 | |
US3268541A (en) | Process for producing 2-phenyl-(or substituted 2-phenyl-) 1, 3-di (4-pyridyl)-2-propanols | |
CN108864185B (zh) | β-膦酰基烯胺衍生物及其制备方法 | |
CN112279805B (zh) | 制备1-(3-甲氧基吡啶-2-基)-2-丙酮的方法 | |
CN109206465B (zh) | 一种合成环磷腺苷的方法 | |
KR101974388B1 (ko) | 알킬 디에틸렌 트리아민 유도체 및 이의 제조방법 | |
CN116621754A (zh) | 吡咯烷酮-3-β’-氨基衍生物的制备方法 | |
CN114292297A (zh) | 一种制备抗病毒药物替诺福韦艾拉酚胺富马酸盐的方法 | |
JP4004082B2 (ja) | 環状ニトログアニジン誘導体の製造法 | |
US4900826A (en) | Process for preparing N6,9-disubstituted adenine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231218 Address after: 236600 intersection of Yingyang road and Chuangye Road, Taihe Economic Development Zone, Fuyang City, Anhui Province (declaration and commitment) Patentee after: Fuyang xinyihua Pharmaceutical Technology Co.,Ltd. Address before: 236600 intersection of Yingyang road and Chuangye Road, Taihe Economic Development Zone, Fuyang City, Anhui Province (declaration and commitment) Patentee before: Fuyang xinyihua Pharmaceutical Technology Co.,Ltd. Patentee before: FUYANG SINEVA MATERIAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |